Cite
HARVARD Citation
Jimenez‐Zepeda, V. et al. (2021). Real‐world outcomes with bortezomib‐containing regimens and lenalidomide plus dexamethasone for the treatment of transplant‐ineligible multiple myeloma: a multi‐institutional report from the Canadian Myeloma Research Group database. British journal of haematology. pp. 532-541. [Online].